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Abstract
The 53 kDa insulin receptor substrate protein (IRSp53) is highly enriched in the brain. Despite
evidence that links mutations of IRSp53 with autism and other neuropsychiatric problems, the
functional significance of this protein remains unclear. We here use light and electron microscopic
immunohistochemistry to demonstrate that IRSp53 is expressed throughout the adult rat brain.
Labeling concentrated selectively in dendritic spines, where it was associated with the
postsynaptic density. Surprisingly, its organization within the PSD of spiny excitatory neurons of
neocortex and hippocampus differed from that within spiny inhibitory neurons of neostriatum and
cerebellar cortex. The present data support previous suggestions that IRSp53 is involved in
postsynaptic signaling, while hinting that its signaling role may differ in different types of
neurons.
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IRSp53 (Insulin Receptor Substrate p53; also known as BAIAP2, Brain-specific
Angiogenesis Inhibitor 1-Associated Protein 2) concentrates in the brain, where it has been
identified as a component of the biochemically-defined postsynaptic density fraction
(Abbott et al., 1999). IRSp53 is a member of the I-BAR group of BAR (Bin-Amphiphysin-
Rvs) domain proteins, which can sense or induce membrane curvature (Zhao et al., 2011).
IRSp53 also acts as a signaling platform for Rho-GTPases (Choi et al., 2005; Oda et al.,
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1999; Yeh et al., 1996). Thus, IRSp53 may serve as a physical linker between the plasma
membrane and the actin cytoskeleton (Scita et al., 2008).
Certain IRSp53 alleles in humans have been linked to neurological problems such as
attention-deficit/hyperactivity disorder, Gilles de la Tourette syndrome, and autism (Paschou
et al., 2004; Ribases et al., 2009; Toma et al., 2011), and its expression is selectively
decreased in Alzheimer’s disease (Zhou et al., 2013), but its function in neurons remains
unclear. In fibroblasts, IRSp53 has been shown to regulate Rac-dependent lamellipodia
formation (Miki et al., 2000) and Cdc42-dependent filopodia formation (Govind et al., 2001;
Krugmann et al., 2001; Lim et al., 2008; Nakagawa et al., 2003; Yamagishi et al., 2004).
These observations led to the hypothesis that IRSp53 might play a key role in dendritic
spines, whose morphology is controlled by their actin cytoskeleton. Accordingly, IRSp53
overexpression in cultured hippocampal neurons increases spine density, while acute
knockdown (or dominant-negative inhibition) of IRSp53 decreases both the density and size
of dendritic spines (Choi et al., 2005). Surprisingly, however, no significant changes in the
density or ultrastructure of dendritic spines were detected in mice lacking IRSp53 (Kim et
al., 2009; Sawallisch et al., 2009), presumably reflecting the effects of compensatory
mechanisms in the intact animal. Nevertheless, spatial learning, novel object recognition,
and contextual fear-conditioning were impaired in IRSp53 knockout mice (Kim et al., 2009;
Sawallisch et al., 2009).
To gain further insight into possible functions of IRSp53 in neurons, we have studied its
regional, cellular, and subcellular localization in the brain of the adult rat. We here show that
IRSp53 is expressed throughout the brain, concentrating in dendritic spines, where it is
closely associated with the PSD. While IRSp53 displayed a strong association with the PSD
in spine-rich neurons from multiple brain regions, its organization within the synapses of
spiny excitatory neurons of neocortex and hippocampus differed from that within spiny
inhibitory neurons of neostriatum and cerebellar cortex, demonstrating intriguing
organizational differences between PSDs in excitatory and inhibitory cells.
MATERIALS AND METHODS
13 male Sprague-Dawley rats (200–350 g, Charles River, Raleigh, NC, 5 for LM, 3 for
GABA immunofluorescence and pre-embedding immunogold, and 5 for postembedding
immunogold) were used for this study. All procedures related to the care and treatment of
animals were in accordance with institutional and NIH guidelines; all animals use protocols
were reviewed and approved by the relevant Institutional Animal Care and Use Committee.
Antibody specificity
Table 1 provides a list of primary antibodies used in this study.
To detect IRSp53, we generated rabbit polyclonal antibodies against the full-length human
protein (aa 1-521, H6-IRSp53) (Choi et al., 2005). This antibody recognizes the two major
IRSp53 bands previously reported (Abbott et al., 1999) (migrating on immunoblot at
apparent molecular weights of ~58 and ~53 kDa) in brain samples from wild-type mice, but
not from IRSp53-knockout mice. Since the primary antibody was affinity-purified, pre-
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adsorption would not be informative. To verify method specificity for postembedding
immunogold, we performed experiments in which primary antibody was omitted, verifying
that immunogold was nearly absent (no more than 2–4 particles/grid square); additionally,
we performed experiments in which primary antibody was replaced with normal rabbit
serum (see Results).
To identify GABAergic synapses, we use a mouse monoclonal antibody raised against
GABA conjugated to BSA (clone 5A9, cat. # MAB316, lot # 2080836, Millipore
Corporation, Billerica, MA). This antibody does not cross-react with other amino acids.
Tissue preparation
After inducing deep anesthesia with sodium pentobarbital (60 mg/kg, i.p.), rats were
intracardially perfused with 500 ml of fixative: 4% freshly-depolymerized paraformaldehyde
in phosphate buffer (PB, 0.1 M, pH 7.4), for LM; a mixture of 4% paraformaldehyde and
0.1% glutaraldehyde in PB, for LM labeling with GABA and pre-embedding EM; or a
mixture of 2% paraformaldehyde and 2% glutaraldehyde in PB, for postembedding EM.
Brains were sectioned at 50 μm and 100 μm on a Vibratome, and collected in cold PB.
Light microscopy
Free-floating sections were permeabilized with 50% ethanol (in PB) for 30 min, and then
incubated in 10% normal donkey serum (NDS). The primary antibody (IRSp53, 1:500) was
then applied overnight. For immunoperoxidase microscopy, sections were then incubated for
3 hours in biotinylated secondary antibody (1:200; Jackson ImmunoResearch, West Grove,
PA) and for 1 hour in ExtrAvidin-peroxidase complex (1:5,000; Sigma, St. Louis, MO);
peroxidase was histochemically visualized with nickel-intensified diaminobenzidine.
Processed sections were mounted on gelatin-coated slides, air dried, and cleared with xylene
before being coverslipped with D.P.X. mountant (BDH Chemicals, Poole, England).
For immunofluorescence microscopy, antigenic sites were visualized with donkey IgG
conjugated to Cy3 (1:200, Jackson ImmunoResearch; West Grove, PA). For double labeling,
the second primary antibody (1:5,000, mouse anti-GABA) was applied overnight and
visualized by a secondary antibody conjugated to Cy5 (1:200, Jackson ImmunoResearch) or
Alexa 488 (1:200, Invitrogen). Some sections were then counterstained with with
NeuroTrace 500/525 (Invitrogen) to selectively visualize neuronal somata. Control
experiments, in which the primary antibodies were omitted, were performed to control for
nonspecific binding of the secondary antibody. Sections were examined with a Leitz DMR
microscope (Leica, Wetzlar, Germany) and a Leica SP2 confocal microscope. Brightfield
and fluorescence large scale images were acquired on a Nikon Eclipse 80i microscope
equipped with a Surveyor/Turboscan automated tiling and imaging system for large area
acquisition (Objective Imaging Ltd., Cambridge, UK) and Retiga EXi color CCD camera
(Qimaging, Surrey, Canada) as the detector.
Electron microscopy
For pre-embedding, free-floating sections were incubated in 1% NaBH4 for 15 minutes (to
quench free aldehyde groups), and 1.5% hydrogen peroxide for ten minutes (to quench
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endogenous peroxidases). After blocking for 20 minutes in 10% normal donkey serum
(NDS), sections were incubated in primary antibody (IRSp53, 1:500) overnight. For pre-
embedding immunoperoxidase staining, sections were then incubated for 3 hours in
biotinylated secondary antibody (1:200–1:500; Jackson ImmunoResearch, West Grove, PA)
and for 1 hour in ExtrAvidin-peroxidase complex (1:5,000; Sigma, St. Louis, MO);
peroxidase was histochemically visualized using a standard DAB-nickel method (Shu et al.,
1988).
For preembedding gold, sections were then incubated with biotinylated donkey-anti rabbit
IgG (1:200, Jackson ImmunoResearch), followed by 1.4 nm gold particles conjugated to
streptavidin (1:100; Nanoprobes, Yaphank, NY). Sections were washed in 0.01 M Na
acetate (to remove phosphate and chloride ions), followed by silver enhancement with
IntenSE-M (Amersham Biosciences). Sections were then post-fixed in 0.5% osmium
tetroxide in 0.1 M PB for 30–45 min and incubated with 1% uranyl acetate in maleate buffer
(0.1 M, pH 6.0) for 45 min. After dehydration, sections were infiltrated with Spurr’s resin
(Electron Microscopy Sciences, Hatfield, PA) and flat-mounted between sheets of
ACLAR® fluoropolymer (Electron Microscopy Sciences, Hatfield, PA) within glass slides.
Sixty-nanometer sections were cut, mounted on 200 mesh copper grids, and contrasted with
uranyl acetate and Sato’s lead.
For postembedding, 100 μm sections were pre-treated in 0.1% calcium chloride in 0.1 M
sodium acetate, rinsed, then cryoprotected in a graded series to 30% glycerol in 0.1 M
sodium acetate. Sections were quick-frozen in methanol chilled with dry ice. Freeze
substitution in 4% uranyl acetate in methanol was carried out in a Leica Automatic Freeze
Substitution System; after rinsing in methanol, section were infiltrated with Lowicryl
HM-20, mounted between sheets of ACLAR supported by pieces of glass slide, and
polymerized with ultraviolet light. After polymerization, regions of interested were cut from
the sections and glued to plastic blocks. Sections were cut at ~70–90 nm with an
ultramicrotome and collected on nickel grids, coated with Coat-Quick. Grids were pre-
treated 15 mins at 60 °C in 0.01 M citrate buffer, pH 6, rinsed in water, blocked in 1% BSA
in TRIS-buffered saline with 0.005% Tergitol NP-10, then incubated overnight at 21–24 °C
with the primary antibody (IRSp53, 1:200 or a mixture of IRSp53, 1:200 and GABA,
1:500). Grids were rinsed, blocked in 1% normal goat serum, and incubated in goat antibody
to rabbit IgG F(ab)2 conjugated to 10-nm gold particles (1:20, Ted Pella, Redding, CA) or a
mixture of goat antibody to mouse IgG F(ab)2 conjugated to 10-nm and goat antibody to
rabbit IgG conjugated to 20-nm gold particles (1:20, Ted Pella). Grids were then rinsed and
counterstained with 1% uranyl acetate, followed by Sato’s lead.
Image analysis
To evaluate the distribution of labeling in different tissue compartments, we first collected
random EM photomontages (each ~ 10 × 10 μm) from neuropil of the stratum radiatum from
CA1 hippocampus. Using ImageJ, we outlined all identifiable spines, PSDs, presynaptic
terminals, mitochondria, and dendritic shafts. Since these were from single sections, many
profiles (especially neuroglia and small axons and dendrites) could not be unambiguously
identified, and were grouped as “other. To assess how much of the immunogold labeling
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might represent noise rather than authentic IRSp53 protein, we examined immunogold-
processed material in which primary antibody had been replaced with normal rabbit serum.
As above, we collected random photomontages (each ~ 10 × 10 μm) from neuropil of the
stratum radiatum from CA1 hippocampus, again outlining all identifiable spines, PSDs,
presynaptic terminals, mitochondria, and dendritic shafts. To compare labeling in GABA-
positive and GABA-negative synapses in the different regions studied, we performed
double-labeling and counted all synapses from ten random photomontages (each ~ 10 × 10
μm) collected from each of neocortex, hippocampus, striatum, and cerebellum.
To investigate the organization of immunogold label associated with the PSD of asymmetric
synapses, we took measurements from 35–40 immunolabeled synapses for each of the four
brain regions studied, from each of three animals. For quantitative analysis of immunogold
particles at synapses we used ImageJ (Schneider et al., 2012). To define “axodendritic”
position, the distance between the center of each gold particle and the outer leaflet of the
postsynaptic membrane was measured. To define the “lateral” synaptic position of a gold
particle, we measured the distance from each end of the PSD to a line drawn perpendicular
to the synapse running through the center of the particle (Valtschanoff and Weinberg, 2001).
Normalized lateral position of each gold particle within the axodendritic peak (from −10 nm
to +50 nm from the postsynaptic membrane) was computed as LN = |(a−b)|/|(a+b)|, where a
and b are tangential distances along the plasma membrane from the center of the gold
particle to the lateral edges of the synaptic specialization; thus LN = 0 for gold particles at
the center of the PSD, and LN = 1 for particles at its edge.
RESULTS
General distribution of IRSp53
IRSp53 protein was detected throughout the rat brain, largely confined to gray matter (Fig.
1). IRSp53 staining was strongest in the olfactory tubercle and lateral hypothalamus. It was
also prominent in olfactory bulb, neocortex, hippocampus, caudoputamen, nucleus
accumbens, and substantia nigra (Fig. 1). IRSp53 staining was much weaker in globus
pallidus, thalamus, and caudal brain stem. Because we wanted to explore the relationship of
IRSp53 to dendritic spines, we focused our attention on spine-rich regions of the brain.
In the neocortex, staining extended through all layers (Fig. 2A). IRSp53 was detected in
somata and dendrites, and in small puncta throughout the neuropil (Figs. 3A–E). The
somato-dendritic staining was most prominent in superficial layer II, while punctate staining
was strongest in layer I. While some of the neuropil staining was clearly in large dendrites,
much of it was in processes too small for accurate identification. Counterstaining with
NeuroTrace (a fluorescent Nissl stain) showed that while the majority of neuronal somata
were immunopositive, a scattered subpopulation of small somata exhibited little or no
staining (arrows in Fig. 3A–D). Our suspicion that these might represent inhibitory
interneurons was confirmed by double labeling with GABA, which showed that GABA-
positive somata were negative for IRSP53 (arrows in Fig. 4A, B).
In the hippocampus, IRSp53 staining was strongest in the dentate gyrus and the CA1 region
of Ammon’s horn, followed by CA2 and CA3 (Fig. 2D, E). In the dentate gyrus, staining
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was strongest in somata of stratum granulosum and in small puncta in the stratum
moleculare (Fig. 3F, G). Staining in CA1-3 was found in the somata and apical dendrites of
pyramidal neurons (Fig. 3H, I). Punctate staining was present throughout the neuropil in
both stratum radiatum and stratum oriens (Fig. 3H, J). As in the neocortex, GABAergic
somata were immunonegative for IRSp53 (Fig. 4C, D)
Staining in both neocortex and hippocampus was excluded from GABAergic neurons.
However, GABAergic neurons are aspiny or sparsely spiny in these structures, leading us to
wonder whether IRSp53 is selectively associated with excitatory neurons, or instead with
spiny neurons per se, regardless of their neurotransmitter. To test this, we studied striatum
and cerebellar cortex, whose principal cells are richly-spiny GABAergic neurons. In the
caudoputamen, IRSp53 staining was prominent in gray matter between fascicles of
myelinated fibers, which themselves were devoid of staining (Fig. 2F, G). Staining was
strong in somata and dendrites of cells likely for their number, size, and distribution to be
medium spiny neurons, and also in numerous puncta in the neuropil (Fig. 5A–C); double-
labeling with GABA confirmed the identity of these cells (data not shown).
In the cerebellum, IRSp53 staining concentrated in the cortex. Only weak staining was
found in the deep nuclei (Fig. 2H, I), and little or no staining was found in the white matter.
Within cerebellar cortex, scatted small somata in the molecular layer (likely to represent
local circuit neurons) were positive; especially in rostral folia. The somata and large
proximal dendrites of Purkinje cells were intensely stained (Fig. 2H, 5D, E).
Immunopositive puncta were found in both the molecular and granule cell layers (Fig. 5D–
F).
In summary, IRSp53 was present throughout the brain, most prominently in regions rich in
dendritic spines. At the cellular level, it concentrated mainly in spiny excitatory and
inhibitory principal neurons.
Subcellular organization
We used electron microscopy to examine the subcellular location of IRSp53.
Immunostaining with DAB revealed small dark patches of label in the soma-dendritic
compartment (Fig. 6A–D). In somata, label was often associated with the Golgi apparatus;
in dendritic shafts, it seemed to associate with microtubules. Patches of labeling were
occasionally found in dendritic spines, in some cases associated with the PSD (Fig. 6E).
Staining was not seen in myelinated fibers.
To get a clearer understanding of the relationship of IRSp53 to intracellular organelles, we
examined material processed for pre-embedding immunogold labeling, followed by silver
intensification (Fig. 6F–I). Intracellular labeling was observed in somata, where particles
were associated with rough endoplasmic reticulum and Golgi apparatus; and large dendritic
shafts, where it was typically associated with microtubules (Fig. 6F, G) and also with
poorly-defined tubulo-vesicular endomembranous structures (Fig. 6H). Gold/silver particles
labeled dendritic spines, but were rarely encountered in preterminal axon segments or in
synapses likely for their morphology to be inhibitory. In contrast to the pattern in dendritic
shafts, labeling in spines often lay near the plasma membrane (Fig. 6I).
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To verify our impression that labeling in dendrites was predominantly intracellular, we
measured the position of 161 gold particles from randomly-selected dendrites, taken from
ten low-magnification photomontages of neuropil (14 × 14 μm), in relationship to the
plasma membrane (Fig. 6J). Particles in dendritic shafts seemed fairly uniformly distributed
within a band ~0.7 μm from the membrane. However, this histogram might be misleading,
since the data were drawn from dendrites of various diameters. Accordingly, we normalized
the particle distribution, such that 0 corresponded to a particle touching the membrane, and 1
to a particle lying in the center of the dendrite. This analysis confirmed that IRSp53 in
dendrites had no clear affinity for the plasma membrane (Fig. 6K).
We used postembedding immunogold labeling to avoid problems of differential antibody
access; though less sensitive than pre-embedding methods, postembedding immunogold is
generally considered to provide an unbiased estimate of antigen distribution. As with pre-
embedding, postembedding gold labeled dendrites and somata, but was seldom detected
over axons. However, labeling in spines was more common than with pre-embedding
methods; this spine labeling was mainly associated with the PSD (Fig. 7), consistent with
published biochemical data that IRSp53 concentrates at the PSD.
In contrast to the prominent label associated with presumed excitatory synapses, double
labeling with GABA suggested that IRSp53 is rarely expressed in synaptic contacts made by
GABAergic terminals. (Fig. 8). To evaluate this difference quantitatively, we counted all
synapses in random fields from the four neuroanatomical regions. Overall, excitatory
synapses were roughly ten times more likely to express IRSp53 in a single section than were
GABAergic synapses, though the ratio varied somewhat in different brain regions (Table 2).
Approximately ¼ of excitatory synapses in neocortex, hippocampus, and cerebellar cortex
displayed labeling, in contrast to nearly ½ of excitatory synapses in striatum (Table 2). The
numerical estimate of this labeling cannot be readily interpreted, since it greatly
underestimates the true content of IRSp53 protein (in part because antigen can only be
detected by postembedding methods at the very surface of the thin section), but the relative
enrichment of labeling in striatum may be significant.
Quantification of label density in different tissue compartments showed that label was ~ 30-
fold enriched over the PSD (Table 3). To ensure that this preferential PSD labeling reflected
the distribution of antigen, rather than simply arising from some nonspecific affinity to the
protein-rich environment of the synapse, we performed experiments in which the primary
antibody was replaced by normal rabbit serum, finding in this case that label was only
marginally enriched over the PSD, in contrast to strong enrichment over mitochondria
(Table 3). The ratiometric data also support that most of the label detected within spine
cytoplasm and presynaptic terminals, though present at far lower densities than at the PSD,
reflects authentic IRSp53. These ratios likely overestimate nonspecific background, since to
allow quantification of PSD labeling with normal serum as substitute for primary antibody,
we had to increase its concentration to levels that gave excessive overall labeling.
Organization at the synapse
Quantitative analysis confirmed our qualitative impression from pre-embedding that label in
spines was often close to the plasma membrane. In fact, we found that more than 80% of
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gold particles representing IRSp53 in dendritic spines (337 of 417 particles) lay within 30
nm of the membrane. This labeling showed a clear association with the PSD. To assess the
organization of IRSp53 in the vicinity of the PSD quantitatively, we measured the
axodendritic distribution of gold particles lying within the lateral borders of the synaptic
specialization. At the synapse, IRSp53 immunogold particle density along the axo-dendritic
axis was maximal over the PSD, with a peak ~20 nm inside the postsynaptic membrane;
labeling density diminished rapidly outside the postsynaptic plasma membrane and also
within the cytoplasmic matrix of the spine (Fig. 9A–D).
To determine whether IRSp53 is uniformly distributed tangentially along the PSD, we
computed the “normalized lateral position” (LN) of gold particles along the membrane (lying
within a window between −10 nm and +50 nm from the postsynaptic plasma membrane; see
Materials and Methods, and diagram at bottom of Fig. 9). For all regions examined, labeling
was strongly associated with the PSD, declining abruptly at its edge. However, in spines
from the neocortex and CA1 hippocampus but not striatum and cerebellum, IRSp53
concentrated at the center of the synapse (Fig. 9E, F), a distribution reminiscent of that
previously reported for NMDA receptors (Kharazia and Weinberg, 1999; Takumi et al.,
1999). To assess whether these distributions could have arisen by chance, we used chi-
square statistics with 4 degrees of freedom (reflecting five bins within the border of the
synaptic specialization in Fig. 9E, F) to assess significance. For both neocortex and
hippocampus, the distribution of particles among the five bins was significantly different
from a uniform distribution (neocortex, p < 0.001, n = 102 synaptic particles; CA1, p < 0.01,
n = 69 particles). In contrast, in spines from striatum and cerebellum, IRSp53 was rather
uniformly distributed along the synapse (striatum, p > 0.6, n = 106 synaptic particles;
cerebellar cortex, p > 0.5, n = 85 particles, Fig. 9G, H).
We computed the mean LN of all particles in this axodendritic window that lay within the
borders of the PSD for each anatomical region, finding mean values of 0.38 ± 0.03 for both
neocortex and hippocampus, and 0.47 ± 0.03 for both striatum and cerebellar cortex. Not
surprisingly, a Wilcoxon rank-sum test revealed that the distribution of synaptic particles in
hippocampus was not significantly different from that in neocortex (p > 0.9), whereas the
distributions in striatum and cerebellum differed from that in neocortex (p < 0.02 for both).
We also computed an “edge-to-center” ratio (defined as the number of particles within the
limits of the PSD with LN > 0.5, divided by the number of particles with LN < 0.5). We
found the edge-to-center ratio for neocortex to be 0.49, and hippocampus, 0.53; whereas the
ratio for striatum was 0.95, and cerebellar cortex, 0.98, confirming that PSD-associated
particles in neocortex and hippocampus concentrate at the center of the synapse, but were
quite uniformly distributed along the synapse in striatum and cerebellar cortex.
DISCUSSION
We here provide the first detailed report of the distribution of IRSp53 protein in the adult
brain. We find that the protein is expressed throughout the gray matter, especially in regions
rich in spiny neurons, where is concentrates at the PSD. Our results suggest that IRSp53 is a
core component of dendritic spines.
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IRSp53 and insulin receptors
IRSp53 can participate in a variety of pathways, including insulin signaling itself. Insulin
may play an important regulatory role in the brain, where it has been proposed to modulate
synaptic plasticity (Dou et al., 2005). While the functional significance of insulin and
insulin-like growth factors in the brain remains unclear (Banks et al., 2012; Ghasemi et al.,
2013; Zhao et al., 1999), insulin receptors have been linked to a variety of physiological
functions, including appetite regulation, fertility and reproduction, and learning and memory
(Banks et al., 2012; Chiu and Cline, 2010). Activation of the insulin receptor promotes
formation of dendritic spines (Lee et al., 2011), and has been shown to regulate the density
of synapses in the developing visual system (Chiu et al., 2008). At the molecular level,
insulin receptors may play an important role in regulation of intracellular trafficking, and
surface expression of ion channels and neurotransmitter receptors (Beattie et al., 2000; Chiu
et al., 2008; Huang et al., 2004; Huang et al., 2003; Liao and Leonard, 1999; Man et al.,
2000; Passafaro et al., 2001; Skeberdis et al., 2001; Wan et al., 1997; Wang and Linden,
2000).
Autoradiography and in situ hybridization (Havrankova et al., 1978; Marks et al., 1990;
Werther et al., 1987) reveal especially high levels of the insulin receptor in the olfactory
bulb, neocortex, hypothalamus and hippocampus; and moderate expression in striatum and
cerebellum; but only weak expression in the thalamus. Interestingly, these results correspond
to the regional distribution of IRSp53 we find in the present study. Moreover, the β-subunit
of the insulin receptor has also been found in synaptosome and PSD fractions (Abbott et al.,
1999). Taken together, these data raise the possibility that IRSp53 may be a key element of
an insulin receptor signaling system at the synapse.
IRSp53 and dendritic morphology
Experiments in cultured neurons show that IRSp53 can regulate dendritic branching. These
effects may be related to the ability of IRSp53, as an I-BAR protein, to sense and/or modify
membrane curvature (Ahmed et al., 2010). If so, one would expect to see the protein
associated with the plasma membrane, but in fact we found that IRSp53 in dendrites was
seldom close to the membrane. Moreover, we saw no evidence of antigen accumulation at
zones of high curvature (e.g., dendritic branches and junctions with spine necks) However,
label did associate with small membrane-bound tubules within dendritic shafts; these
structures might be important for dendritic development and branching.
In any case, the large majority of IRSp53 in dendrites was cytoplasmic and associated with
filaments, likely representing protein in transit. Since the protein can move quickly from
dendrites to spines in response to neuronal activity (Hori et al., 2005), we speculate that
IRSp53 in dendritic shafts may represent a reserve pool (though it remains possible that the
protein may have a specific function in dendrites). In contrast, IRSp53 in spines was
associated with the membrane, and thus is suitably positioned to modulate spine shape. This
would be consistent with current views that morphologic plasticity in the adult is far more
prominent in spines than dendritic shafts.
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IRSp53 and the postsynaptic density
Our postembedding EM analysis documents that IRSp53 in the adult brain is highly
concentrated at the PSD, as previously suggested by biochemical fractionation studies.
These data are consistent with biochemical evidence that IRSp53 can bind to several key
PSD scaffold proteins, including PSD-95 (via its PDZ motif) and Shank (via its SH3
domain); in fact, IRSp53 has been proposed to act as a bridge between these two proteins
(Bockmann et al., 2002; Choi et al., 2005; Soltau et al., 2002). This proposal is consistent
with the present data showing that IRSp53 (mean axodendritic position 16.9 ± 0.7 nm
cytoplasmic to the postsynaptic membrane) lies between PSD-95 (previously reported
axodendritic position 11.9 ± 31.2 nm) and Shank (24.1 ± 31.7 nm, (Valtschanoff and
Weinberg, 2001)). Interestingly, the Rho protein CDC42, implicated in regulation of spine
shape, has been shown to regulate formation of this IRSp53 trimeric complex (Soltau et al.,
2004). Accordingly, we suggest that IRSp53 may link postsynaptic signal transduction to
actin remodeling.
Regional differences in the distribution of IRSp53 along the synapse
IRSp53 was expressed at high levels in brain regions rich in spiny neurons. Though often
presumed to represent a uniform population, dendritic spines from different type of neurons
can differ in ultrastructure and protein composition, and may employ distinct signaling
pathways (Harris and Weinberg, 2012; O’Rourke et al., 2012; Petralia et al., 1994). For
example, proteomic analysis shows important molecular differences between forebrain and
cerebellar PSDs (Cheng et al., 2006). The present results show that IRSp53 in the pyramidal
cells of neocortex and hippocampus concentrated at the center of the PSD, whereas IRSp53
in the spiny inhibitory neurons of neostriatum and cerebellar cortex distributed uniformly
along the synapse. These regional differences in the tangential organization of IRSp53
within the PSD further support the notion that dendritic spines are not uniform across brain
regions.
As a modular protein with multiple binding domains, IRSp53 may be involved in a variety
of protein complexes participating in distinct signaling pathways. Accordingly, the
differences we detected in IRSp53 localization may be related to different synaptic
functions. As mentioned above, IRSp53 can bind both PSD-95 and Shank, key elements of
the NMDA receptor signaling complex (Dosemeci et al., 2007; Husi et al., 2000). Moreover,
the tangential distribution profile of IRSp53 we found in cortex and hippocampus closely
resembles that previously reported for NMDA receptors (Kharazia and Weinberg, 1999;
Takumi et al., 1999). These data, along with recent evidence that IRSp53 may play a direct
role in regulating NMDA receptors and/or their numbers at the PSD, implicate IRSp53 as a
component of the NMDAR signaling complex in cortex and hippocampus. In contrast, in
Purkinje cells, which contain little NMDA receptor (Cheng et al., 2006; Petralia et al.,
1994), IRSp53 was more uniformly distributed. IRSp53 has been shown to bind to the
multifunctional actin-bundling protein espin (also enriched in the PSD), a protein only
expressed in cerebellar Purkinje cells (Sekerkova et al., 2003). Thus IRSp53 in Purkinje
cells may be part of a distinct molecular complex.
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In summary, while the functional significance of IRSp53 in the adult brain remains unclear,
the present evidence suggests that it acts mainly at the PSD, that it may play a role in the
insulin signaling system, and that it may play different roles in different synapses.
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Immunofluorescence (A) and immunoperoxidase (B) staining for IRSp53 in parasagittal sections of the rat brain. Staining is
strong in regions rich in spiny neurons, including neocortex, hippocampus, striatum, and cerebellar cortex.
Scale bar = 0.5 cm
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Immunofluorescence labeling for IRSp53 in coronal sections. A–C, neocortex (S1); D–E, hippocampus; F–G, basal ganglia and
thalamus; H–I, cerebellum. The sections illustrated were also stained with NeuroTrace to identify anatomical features (C, E, G,
I). Fluorometric plot (left panel in A) provides a quantitative view of the dense immunostaining at the superficial border of
cortical layer II. Neuropil of layer I is strongly immunopositive, but the “peak” at the top of the section is an edge artifact.
Abbreviations: Th: thalamus, GP: globus pallidus, St: striatum, NeuroT: NeuroTrace
Scale bar = 0.5 mm in A–C; 1 mm in D–I.
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Immunofluorescence labeling for IRSp53 in neocortex (A–B, layer II; C–E, layer V) and hippocampus (F, G, dentate gyrus; H–
J, CA1). Green channel, IRSp53; red channel, NeuroTrace. Scattered small neurons are immunonegative for IRSp53 (white
arrows in A–D, H–I).
Abbreviations: SM: stratum moleculare, SG: stratum granulosum, PL: polymorphic layer; SR: stratum radiatum, SP: pyramidal
cell layer, SO: stratum oriens, NeuroT: NeuroTrace
Scale bar = 25 μm in A–D, F–I; 10 μm in E, J.
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Double labeling for IRSp53 and GABA in neocortex (A, B, layer V), and hippocampus (C, D, CA1 field). Scattered GABAergic
somata (white arrows) are immunonegative for IRSp53.
Abbreviations: SR: stratum radiatum, SP: pyramidal cell layer, SO: stratum oriens.
Scale bar = 25 μm in A–D.
Burette et al. Page 18























Immunofluorescence labeling for IRSp53 in neostriatum (A–C), and cerebellar cortex (D–F). White arrows in D, E point to
weakly-immunopositive interneurons in the molecular layer.
Abbreviations: ML: molecular layer; PC: Purkinje cell layer, GL: granule cell layer.
Scale bar = 25 μm in A, B, D, E; 10 μm in C, F.
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Electron micrographs of pre-embedding labeling for IRSp53. All images are from layers II–III of S1 neocortex; A–E are from
immunoperoxidase material; F–I are from silver-enhanced nanogold. A, patches of nickel-intensified DAB immunoreaction in
the soma of a small pyramidal cell. Label is in cytoplasm, excluded from nucleus. B, higher magnification image from another
cell shows reaction product associated with rough endoplasmic reticulum and Golgi apparatus. C, large proximal dendrite
contains numerous patches of immunoreaction. D, immunoreaction is associated with microtubules in a thin dendritic shaft. E,
small patch of immunoreaction at the cytoplasmic fringe of the PSD of a dendritic spine. F, pre-embedding silver-enhanced
immunogold shows immunolabel associated with microtubules (boxed area on left, enlarged in G) and with tubulovesicular
structures (boxed area on right, enlarged in H). I, high-magnification image shows silver-enhanced gold particle lying close to
the PSD in a small dendritic spine. J, histogram shows distance of gold particles to the plasma membrane (N = 161 particles
from ten micrographs of randomly-selected dendritic shafts). K, histogram shows the same data, replotted to show “normalized
distance” such that 0 corresponds to membrane, and 1 to center of dendrite (see inset on left).
Scale bar = 1 μm in A; 500 nm in B, C, D; 200 nm in E, 500 nm in F, G, H; 200 nm in I.
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Postembedding labeling for IRSp53 (arrows point to 10 nm gold particles). A, low-magnification view of neocortex shows a
field with three immunopositive dendritic spines; label is associated with the synapse. B, higher magnification view of an
immunopositive spine in cortex. C, large immunopositive spine in hippocampus. D, large spine in neostriatum; three gold
particles are all associated with PSD. E, immunolabeled synapse in cerebellum; gold particle lies near the edge of the PSD. A,
B: layer II–III cortex; C, CA1 hippocampus (stratum radiatum); D, striatum, E, cerebellum (molecular layer).
Scale bar = 400 nm in A; 100 nm in B–E.
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Postembedding double labeling for IRSp53 (20 nm gold particles) and GABA (10 nm particles). IRSp53 labeling was often seen
at postsynaptic sites of synapses likely, for their thickened postsynaptic density and GABA immunonegativity, to be
glutamatergic (blue pseudocolored profiles), but rarely postsynaptic to GABAergic terminals (pink). A: neocortex layers II–III
(S1); B, stratum radiatum of CA1 hippocampus; C, striatum, D, molecular layer, cerebellar cortex.
Scale bar = 200 nm in A–D.
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Synaptic distribution of immunogold labeling. A–D, histograms in the upper row show the distribution of immunolabeling in the
axodendritic axis (20 nm bins); light gray bars represent labeling outside the plasma membrane of the spine. The pattern of
labeling was generally consistent for cortex (A), hippocampus (B), striatum (C), and cerebellum (D), peaking ~20 nm inside the
postsynaptic plasma membrane. E–H, histograms in the lower row show distribution of label tangentially along the synapse,
normalized such that 0 corresponds to the center of the PSD, and 1.0 to its edge (see diagram at bottom). While restricted to the
synapse for all regions examined, labeling in cortex and hippocampus (E, F) concentrated at the center of the PSD, whereas
labeling in striatum and cerebellum (G, H) spread uniformly along the PSD. Y-axis for each histogram is normalized so that the
largest bin corresponds to 1.0 units, and the origin corresponds to zero.
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Table 1
Primary Antibodies
Antigen Immunogen Source Dilution
IRSp53 Full-length IRSp53 (aa 1-521, H6-IRSp53) Choi et al., 2005 1:500
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Table 2
Excitatory synapses Inhibitory synapses
Cerebral cortex 24% 1.4%
Hippocampus 28% 2.0%
Striatum 42% 2.5%
Cerebellar cortex 25% 4.7%3
Percentage of synapses that contain at least one immunogold particle, in random single thin sections.
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Table 3
IRSp53 Serum Ratio
Total area 0.47 ± 0.04 0.60 ± 0.02 0.78
PSDs 15.98 ± 3.22 1.12 ± 1.12 14.27
Spines 0.49 ± 0.18 0.23 ± 0.10 2.13
Terminals 0.58 ± 0.13 0.44 ± 0.10 1.32
Mitochondria 1.00 ± 0.27 3.12 ± 0.36 0.32
Dendritic shafts 0.28 ± 0.08 0.49 ± 0.07 0.57
Others 0.32 ± 0.05 0.69 ± 0.23 0.46
Mean number of gold particles/μm2 ± standard error
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